TMDX

TransMedics Group, Inc. Common Stock#2 · 2022EPA

Yearly return

+203%

Peak return

+216%

Max drawdown

-51%

ADR (20 days)

+4.9%

Base

22 days / -27.9%

Prior run

+182%

Breakout volume

13.0x

Pivot

$27.67

Catalyst Earnings/Guidance2022-05-03TransMedics (TMDX) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research

Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare TMDX with the current market directly.